Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 19;5(2):110-115.
doi: 10.1016/j.ijwd.2018.10.020. eCollection 2019 Jun.

Pediatric melanoma-The whole (conflicts of interest) story

Klaus Rose  1 , Jane M Grant-Kels  2
Affiliations
Review

Pediatric melanoma-The whole (conflicts of interest) story

Klaus Rose et al. Int J Womens Dermatol. .
No abstract available

Keywords: Developmental pharmacology; FDA pediatric written request; Pediatric clinical pharmacology; Pediatric investigation plan; Pediatric legislation; Pediatric melanoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adamson P.C. Improving the outcome for children with cancer: Development of targeted new agents. CA Cancer J Clin. 2015;65(3):212–220. - PMC - PubMed
    1. American Academy of Pediatrics, Committee on Drugs Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics. 1977;60(1):91–101. - PubMed
    1. American Academy of Pediatrics, Committee on Drugs Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics. 1995;95(2):286–294. - PubMed
    1. American Academy of Pediatrics, Committee on Drugs Uses of drugs not described in the package insert (off-label uses) Pediatrics. 2002;110(1 Pt 1):181–183. - PubMed
    1. Bartenstein D.W., Kelleher C.M., Friedmann A.M., Duncan L.M., Tsao H., Sober A.J. Contrasting features of childhood and adolescent melanomas. Pediatr Dermatol. 2018;35(3):354–360. - PMC - PubMed